Sangamo Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.27 | -100% | -8.5 | -100% |
| P/S |
|
0.4157 | 33.44 | -98.76% |
|
|
| P/BV |
|
0.8839 | 4.64 | -80.96% |
|
|
| P/FCF |
|
-0.6598 | 42.53 | -101.55% |
|
|
| Ev/Ebitda |
|
-0.7184 | -17.68 | -95.94% |
|
|
| Ev/S |
|
0.3755 | 22.59 | -98.34% |
|
|
| Ev/FCF |
|
-0.269 | 47.55 | -100.57% |
|
|
| E/P |
|
-1.59 | 0.0182 | -8836.26% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-52.26 | -14.2 | 267.94% | -107.89 | -51.56% |
| ROE |
|
-311.06 | 9.78 | -3279.73% |
|
|
| ROA |
|
-155.96 | 0.33 | -47353.24% |
|
|
| ROIC |
|
-39.8 | 7.63 | -621.33% |
|
|
| ROS |
|
-146.3 | -26.41 | 453.88% |
|
|
| ROCE |
|
-137.89 | 14.5 | -1050.85% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.4137 | -3.87 | -89.32% | -0.3603 | +14.82% |
| Nеt Debt/Ebitda |
|
0.0771 | -4.24 | -101.82% |
|
|
| Debt/Ratio |
|
0.2305 | 0.1853 | 24.39% |
|
|
| Debt/Equity |
|
0.6001 | 1.56 | -61.61% |
|
|
| Debt/Net Income |
|
-0.1478 | 10.06 | -101.47% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.235 | -100% |
|
|
| Average dividend growth |
|
0 | 1.41 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.486 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
8/10
|
72.1 | 30.62 | 135.47% | ||
| Growth impulse Ebitda in 5 years |
|
-16.89 | -17.42 | -3.04% | ||
| Growth impulse Net Income in 5 years |
|
240.15 | -52.26 | -559.53% | ||
| Growth impulse FCF in 5 years |
|
49 | -31.68 | -254.67% | ||
| Growth impulse EPS in 5 years |
|
118.54 | -61.82 | -291.75% |
IP Score
4.55/10
